ProMIS Neurosciences Inc PMN

Drinking the wrong Koolaid with Phase 1

[FarmerBetty]

Provide a company that exploded after phase 1 testing in Alzheimers clinical trials? 

75% of companies past phase 1 of clinical testing which is to a small group testing safety and tolerability.

Phase 2 and 3 tell the story !

[Trek1701]

You must be new here. Biogen's market cap increased by about $40 billion after encouraging results from phase 1 for BIIB037 in 2015. That trial measured benefits (cognition) as well as safety. Might have been a phase 1b but definitely not a phase 2 or 3. I think at least a few would describe a $40 billion market cap increase as "exploded". All it takes is a couple of minutes to

[FarmerBetty]

Took the offer and looked it up, Heres why Biogen lost 20 billion in market value in July 2015. "The primary culprits were weaker-than-expected- second quarter earning results and early stage data involving Alzheimers drug aducaumab that didn't exactly thrill investors".

[Luxor101]

Look at Biogen in 2015 with phase one clinical results and think where this can go.